Literature DB >> 23119425

Human papillomaviruses in hypopharyngeal squamous cell carcinoma.

M Hoffmann1, B J Folz, A M Niemann, S Gottschlich, B M Lippert, C G Mahnke, J A Werner.   

Abstract

Human papillomaviruses (HPV) have been detected in squamous cell carcinoma (SCC) of the aerodigestive tract with varying frequency of 10%-100% mainly due to detection methods and primer pairs used. Polymerase chain reaction (PCR) is the most sensitive and Southern blot hybridization (SBH) the most specific detection method of HPV DNA. Both methods achieve the most reliable results. 22 SCC DNA samples of the hypopharynx were analyzed by type specific and consensus primer PCR and Southern blot analysis. HPV was detected in 5/22 (22.6%) hypopharyngeal SCC specimens. HPV 18 and HPV 45 were identified in one case each. An HPV prevalence of 23% is a realistic approximation in hypopharyngeal SCC. The high rate of HPV positive only detected by non type specific detection methods indicates the presence of previously undescribed HPV types.

Entities:  

Year:  1998        PMID: 23119425      PMCID: PMC3465070          DOI: 10.1007/BF03006998

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  12 in total

1.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Authors:  E Guerrero; R W Daniel; F X Bosch; X Castellsagué; N Muñoz; M Gili; P Viladiu; C Navarro; M L Zubiri; N Ascunce
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 2.  Recent advances in the polymerase chain reaction.

Authors:  H A Erlich; D Gelfand; J J Sninsky
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

3.  Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas.

Authors:  M F Baay; W G Quint; J Koudstaal; H Hollema; J M Duk; M P Burger; E Stolz; P Herbrink
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes.

Authors:  P J Snijders; A J van den Brule; H F Schrijnemakers; G Snow; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

5.  Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies.

Authors:  A J van den Brule; E C Claas; M du Maine; W J Melchers; T Helmerhorst; W G Quint; J Lindeman; C J Meijer; J M Walboomers
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

6.  Detection of human papilloma virus type 16 DNA in oral squames from normal young adults.

Authors:  H Jalal; C M Sanders; S S Prime; C Scully; N J Maitland
Journal:  J Oral Pathol Med       Date:  1992-11       Impact factor: 4.253

Review 7.  Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers.

Authors:  M S Brandwein; G J Nuovo; H Biller
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-04       Impact factor: 1.547

Review 8.  Human papillomaviruses.

Authors:  H zur Hausen; E M de Villiers
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

9.  Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients.

Authors:  V Shamanin; M Glover; C Rausch; C Proby; I M Leigh; H zur Hausen; E M de Villiers
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Amplification and specific detection of transforming gene region of human papillomavirus 16, 18 and 33 in cervical carcinoma by means of the polymerase chain reaction.

Authors:  M Shimada; M Fukushima; H Mukai; I Kato; A Nishikawa; K Fujinaga
Journal:  Jpn J Cancer Res       Date:  1990-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.